Cargando…

The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea

Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (20...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Dae Hyun, Sohn, Won, Jeong, Jae Yoon, Oh, Hyunwoo, Lee, Jae Gon, Yoon, Eileen L., Kim, Tae Yeob, Nam, Seungwoo, Sohn, Joo Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726277/
https://www.ncbi.nlm.nih.gov/pubmed/36482612
http://dx.doi.org/10.1097/MD.0000000000031639
_version_ 1784844740520312832
author Lim, Dae Hyun
Sohn, Won
Jeong, Jae Yoon
Oh, Hyunwoo
Lee, Jae Gon
Yoon, Eileen L.
Kim, Tae Yeob
Nam, Seungwoo
Sohn, Joo Hyun
author_facet Lim, Dae Hyun
Sohn, Won
Jeong, Jae Yoon
Oh, Hyunwoo
Lee, Jae Gon
Yoon, Eileen L.
Kim, Tae Yeob
Nam, Seungwoo
Sohn, Joo Hyun
author_sort Lim, Dae Hyun
collection PubMed
description Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (2005–2019). We retrospectively collected data from 45,632 subjects who underwent anti-HAV IgG testing without evidence of acute HAV infection at four centers in the capital area of South Korea between January 2005 and December 2019. The seroprevalence of anti-HAV IgG was analyzed according to age and compared among seven age groups and five time periods. Additionally, age-period-cohort analyses were used to identify the age, period, and cohort effects of the seroprevalence of anti-HAV IgG. The mean age of the enrolled subjects was 39.2 ± 19.2 years, and the average anti-HAV IgG positivity rate was 66.4%. During the 15 years, the seroprevalence of anti-HAV IgG in people aged 0 to 19 years significantly increased over time (P < .001). In people aged 20 to 29 years, the seroprevalence slightly decreased to that of the early 2010s (31.3% in 2005–2007 to 19.7% in 2011–2013) but rebounded to 39.5% in 2017 to 2019. In contrast, the seroprevalence of anti-HAV IgG in those aged 30 to 49 years decreased over time (P < .001). The seroprevalence of anti-HAV IgG in those aged 20 to 39 years in 2017 to 2019 was still less than 40%. In addition, the seroprevalence of anti-HAV IgG in people aged 50 to 59 years has recently decreased. Since the introduction of the universal vaccination, the seroprevalence of anti-HAV IgG in children and young adults has gradually increased. However, the seroprevalence of anti-HAV IgG in people in their 20s remains low, and the seroprevalence of anti-HAV IgG in people in their 30s and 40s is gradually decreasing. Therefore, a new strategy for HAV vaccination is needed for those in their 20s to 40s.
format Online
Article
Text
id pubmed-9726277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-97262772022-12-09 The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea Lim, Dae Hyun Sohn, Won Jeong, Jae Yoon Oh, Hyunwoo Lee, Jae Gon Yoon, Eileen L. Kim, Tae Yeob Nam, Seungwoo Sohn, Joo Hyun Medicine (Baltimore) 4500 Although universal vaccination has been administered to toddlers, South Korea has had periodic nationwide outbreaks of acute hepatitis A since the late 2000s. We examined the chronological changes in the seroprevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) over the past 15 years (2005–2019). We retrospectively collected data from 45,632 subjects who underwent anti-HAV IgG testing without evidence of acute HAV infection at four centers in the capital area of South Korea between January 2005 and December 2019. The seroprevalence of anti-HAV IgG was analyzed according to age and compared among seven age groups and five time periods. Additionally, age-period-cohort analyses were used to identify the age, period, and cohort effects of the seroprevalence of anti-HAV IgG. The mean age of the enrolled subjects was 39.2 ± 19.2 years, and the average anti-HAV IgG positivity rate was 66.4%. During the 15 years, the seroprevalence of anti-HAV IgG in people aged 0 to 19 years significantly increased over time (P < .001). In people aged 20 to 29 years, the seroprevalence slightly decreased to that of the early 2010s (31.3% in 2005–2007 to 19.7% in 2011–2013) but rebounded to 39.5% in 2017 to 2019. In contrast, the seroprevalence of anti-HAV IgG in those aged 30 to 49 years decreased over time (P < .001). The seroprevalence of anti-HAV IgG in those aged 20 to 39 years in 2017 to 2019 was still less than 40%. In addition, the seroprevalence of anti-HAV IgG in people aged 50 to 59 years has recently decreased. Since the introduction of the universal vaccination, the seroprevalence of anti-HAV IgG in children and young adults has gradually increased. However, the seroprevalence of anti-HAV IgG in people in their 20s remains low, and the seroprevalence of anti-HAV IgG in people in their 30s and 40s is gradually decreasing. Therefore, a new strategy for HAV vaccination is needed for those in their 20s to 40s. Lippincott Williams & Wilkins 2022-12-02 /pmc/articles/PMC9726277/ /pubmed/36482612 http://dx.doi.org/10.1097/MD.0000000000031639 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 4500
Lim, Dae Hyun
Sohn, Won
Jeong, Jae Yoon
Oh, Hyunwoo
Lee, Jae Gon
Yoon, Eileen L.
Kim, Tae Yeob
Nam, Seungwoo
Sohn, Joo Hyun
The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title_full The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title_fullStr The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title_full_unstemmed The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title_short The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea
title_sort chronological changes in the seroprevalence of anti-hepatitis a virus igg from 2005 to 2019: experience at four centers in the capital area of south korea
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726277/
https://www.ncbi.nlm.nih.gov/pubmed/36482612
http://dx.doi.org/10.1097/MD.0000000000031639
work_keys_str_mv AT limdaehyun thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT sohnwon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT jeongjaeyoon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT ohhyunwoo thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT leejaegon thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT yooneileenl thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT kimtaeyeob thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT namseungwoo thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT sohnjoohyun thechronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT limdaehyun chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT sohnwon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT jeongjaeyoon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT ohhyunwoo chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT leejaegon chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT yooneileenl chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT kimtaeyeob chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT namseungwoo chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea
AT sohnjoohyun chronologicalchangesintheseroprevalenceofantihepatitisavirusiggfrom2005to2019experienceatfourcentersinthecapitalareaofsouthkorea